Dougherty & Co Starts U.S. Physical Therapy (USPH) at Buy, Price Target Calls for 46% Upside

Dougherty & Co initiates coverage on shares of U.S. Physical Therapy (NASDAQ: USPH) with a Buy rating and $35 price target.

The firm calls USPH a solid well managed company which has presented investors with 25 percent compound adjusted EPS growth over the past five years. The company has a clean balance sheet and is a leader in the attractive physical therapy market with a proven replicable business model.

Dougherty claims that shares are currently undervalued and is calling for 46 percent upside with its price target. A lot of the upside reflects its belief that earnings estimates are conservative and that the company will release its results well above.

For more ratings news on U.S. Physical Therapy click here and for the rating history of U.S. Physical Therapy click here.

Shares of U.S. Physical Therapy closed at $23.87 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• U.S. Physical Therapy names Nchacha Etta as CFO, effective Sept. 2026